Doxorubicin/ifosfamideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1967卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43958-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：151 / 151

相关论文

共 50 条

[41] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1973 (1) : 107 - 107
[42] Doxorubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 198 - 198
[43] Dactinomycin/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1979 (1) : 141 - 141
[44] Doxorubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 190 - 190
[45] Cyclophosphamide/doxorubicin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1974 (1) : 121 - 121
[46] Doxorubicin-liposomalLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 198 - 198
[47] Doxorubicin/ifosfamide/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 200 - 200
[48] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 143 - 143
[49] Doxorubicin/ifosfamide/selumetinibLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 182 - 182
[50] Cisplatin/doxorubicin/fluorouracilLack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 145 - 145

← 1 2 3 4 5 →